M&G plc’s Medpace MEDP Stock Holding History

M&G plc’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-27,508	Closed	-$11.3M	–	424
2024 Q2	$11.3M	Buy	27,508 +3,040	+12%	+$1.2M	0.04%	179
2024 Q1	$9.89M	Buy	+24,468	New	+$8.6M	0.04%	202

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

M&G plc's MEDP Position: Q3 2024 in Review

M&G plc sold out of Medpace (MEDP) in Q3 2024, closing a stake of 27,508 shares — an estimated $11.3M sold.

M&G plc first reported a position in MEDP in Q1 2024 and held it in 2 quarters. The position peaked at $11.3M in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

M&G plc reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
M&G plc sold 27,508 Medpace shares in Q3 2024, an estimated $11.3M.
M&G plc first reported a position in Medpace in Q1 2024 and held it in 2 quarters.
M&G plc's Medpace position peaked at $11.3M in Q2 2024.
583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on M&G plc's 13F filing for Q3 2024, filed 31 Oct 2024.